Clinical Trials Browser

Prostate Cancer Metastatic × talazoparib × Genitourinary × Clear all

NCT04824937 2021-04-01

Telaglenastat + Talazoparib In Prostate Cancer

Phase 2 Unknown

Prostate Cancer Metastatic